Stockscreener 앱 받기
1.46
2.67%
-0.04
전일 마감가:
$1.50
열려 있는:
$1.5
하루 거래량:
27,800
Relative Volume:
0.64
시가총액:
$2.02M
수익:
$357.90K
순이익/손실:
$-11.06M
주가수익비율:
-1.3035
EPS:
-1.1201
순현금흐름:
$-11.90M
1주 성능:
-22.75%
1개월 성능:
-44.70%
6개월 성능:
-71.92%
1년 성능:
-95.44%
1일 변동 폭
$1.28
$1.50
1주일 범위
$1.28
$1.95
52주 변동 폭
$1.28
$34.40
Biorestorative Therapies Inc Stock (BRTX) Company Profile
명칭
Biorestorative Therapies Inc
전화
(631) 760-8100
주소
40 MARCUS DRIVE, MELVILLE
Compare BRTX vs VRTX, MRNA, REGN, ARGX, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BRTX
Biorestorative Therapies Inc
|
1.46 | 2.02M | 357.90K | -11.06M | -11.90M | -1.1201 |
VRTX
Vertex Pharmaceuticals Inc
|
508.75 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
236.50 | 94.42B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
796.34 | 81.99B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.27 | 53.22B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.08 | 42.32B | 5.76B | 514.49M | 1.10B | 4.4813 |
Biorestorative Therapies Inc Stock (BRTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-10-06 | 다운그레이드 | Maxim Group | Buy → Hold |
Biorestorative Therapies Inc 주식(BRTX)의 최신 뉴스
BioRestorative Therapies reports resignation of vice president of R&D By Investing.com - Investing.com South Africa
BioRestorative Therapies reports resignation of vice president of R&D - Investing.com
Form 8K BioRestorative Therapies Inc For: 11 September By Investing.com - Investing.com India
BioRestorative Therapies reports resignation of vice president of R&D By Investing.com - Investing.com UK
BioRestorative Therapies reports resignation of vice president of R&D - Investing.com
Form 8K BioRestorative Therapies Inc For: 11 September By Investing.com - Investing.com Canada
Form 8K BioRestorative Therapies Inc For: 11 September By Investing.com - Investing.com UK
BioRestorative Therapies Faces Disputed Executive Resignation Claim - TipRanks
BioRestorative Therapies Inc expected to post a loss of $2.50 a shareEarnings Preview - TradingView
BioRestorative Therapies, Inc. Revenue Breakdown – MUN:9OF0 - TradingView
BioRestorative Therapies, Inc. Earnings and Revenue – FWB:9OF0 - TradingView
BioRestorative Therapies Inc expected to post a loss of 12 cents a shareEarnings Preview - TradingView
Biorestorative Therapies To Carry Out 1-for-20 Reverse Stock Split On September 8th, 2026 - Moomoo
BioRestorative Therapies Announces Reverse Stock Split - Ortho Spine News
BioRestorative Therapies Announces Reverse Stock Split - The Manila Times
BioRestorative Therapies Announces 1-for-20 Reverse Stock Split - TipRanks
Biorestorative Therapies Announces Reverse Stock Split - TradingView
BioRestorative Therapies: Board Approves 1-For-20 Reverse Split >BRTX - Moomoo
BioRestorative Therapies Names New Interim CEO and CFO - minichart.com.sg
BioRestorative Therapies Announces Reverse Stock Split - Yahoo Finance
BioRestorative Therapies Inc (BRTX) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
BioRestorative Therapies Inc (BRTX) Key Financial Ratios – Valuation, Profitability & More - Value Research
BioRestorative Therapies Inc (BRTX) Peer Comparison – Compare with Others - Value Research
BRTX Q1 2026 Earnings: Narrower Net Loss Beats Estimates as Pipeline AdvancesQuarterly Earnings Report - vinanet.vn
BioRestorative Therapies Faces Nasdaq Delinquency Notice Risk - TipRanks
BioRestorative Therapies Received Notice of Noncompliance - TradingView
BioRestorative (BRTX) Chart: Slides 0.98% to $0.21 for the Current Session; Price Levels: Price Remains Between $0.20 Support and $0.22 Resistance in the Latest ReadingFibonacci Retracement - vinanet.vn
BioRestorative (BRTX) Move: Retreats 2.40% to $0.22 for the Current Session; Range Check: the Current Price Sits Inside the Supplied Technical Range in the Latest ReadingVolume Spike Alerts - vinanet.vn
BioRestorative Therapies Inc expected to post a loss of 12 cents a shareEarnings Preview - TradingView
MSN Money - MSN
BioRestorative Therapies (NASDAQ:BRTX): Why Is Cell-Therapy Development And Manufacturing Readiness in Focus Today? - Kalkine Media
BioRestorative Therapies (NASDAQ:BRTX): Why Is Cell-Therapy Development And Funding in Focus Today? - Kalkine Media
BRTX Q2'26 Earnings: EPS estimate is (0.10) USD - TradingView
BioRestorative Therapies (BRTX) Holds Near $0.23 as Modest Gains Build on Thin VolumeFundamentals - dars.gov.et
BioRestorative Therapies (BRTX) Holds Near $0.23 as Modest Gains Build on Thin VolumeOption Breadth - dars.gov.et
BioRestorative Therapies (BRTX) Holds Near $0.23 as Modest Gains Build on Thin VolumeStrong Buy Stocks - vinanet.vn
Form 8K BioRestorative Therapies Inc For: 14 August - Investing.com India
BioRestorative Therapies suspends shipments of ExoCR and BioX products for review - Investing.com Australia
BioRestorative Therapies suspends shipments of ExoCR and BioX products for review - Investing.com
Form 8K BioRestorative Therapies Inc For: 14 August By Investing.com - Investing.com Nigeria
Form 8K BioRestorative Therapies Inc For: 14 August By Investing.com - Investing.com Australia
BioRestorative Therapies suspends shipments of ExoCR and BioX products for review - Investing.com Canada
BioRestorative Therapies suspends shipments of ExoCR and BioX products for review - Investing.com India
Form 8K BioRestorative Therapies Inc For: 14 August By Investing.com - Investing.com Canada
BioRestorative Therapies Delays Quarterly SEC Filing - TipRanks
BioRestorative Therapies Halts ExoCR and BioX Shipments - TipRanks
Biorestorative Therapies Suspends All Orders, Shipments Of Exocr, Biox Biocosmeceutical Product Lines Effective Immediately, On Aug 7 - TradingView
BioRestorative Therapies (BRTX) delays Q2 10-Q amid losses and going-concern risk - Stock Titan
BioRestorative Therapies, Inc. Suspends All Orders And Shipments Of Biocosmeceutical Product Lines - marketscreener.com
BRTX Q2'26 Earnings: revenue estimate is 600.00K USD - TradingView
Biorestorative Therapies Inc (BRTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.35%
자본화:
|
볼륨(24시간):